PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
Insulin signaling in health and disease
AR Saltiel - The Journal of clinical investigation, 2021 - Am Soc Clin Investig
The molecular mechanisms of cellular insulin action have been the focus of much
investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in …
investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in …
Molecular dynamics simulations in drug discovery and pharmaceutical development
Molecular dynamics (MD) simulations have become increasingly useful in the modern drug
development process. In this review, we give a broad overview of the current application …
development process. In this review, we give a broad overview of the current application …
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
ME Bahar, HJ Kim, DR Kim - Signal transduction and targeted therapy, 2023 - nature.com
Metastatic dissemination of solid tumors, a leading cause of cancer-related mortality,
underscores the urgent need for enhanced insights into the molecular and cellular …
underscores the urgent need for enhanced insights into the molecular and cellular …
Targeting aberrant RAS/RAF/MEK/ERK signaling for cancer therapy
U Degirmenci, M Wang, J Hu - Cells, 2020 - mdpi.com
The RAS/RAF/MEK/ERK (MAPK) signaling cascade is essential for cell inter-and intra-
cellular communication, which regulates fundamental cell functions such as growth, survival …
cellular communication, which regulates fundamental cell functions such as growth, survival …
A model for RAS mutation patterns in cancers: finding the sweet spot
S Li, A Balmain, CM Counter - Nature Reviews Cancer, 2018 - nature.com
The three RAS genes—HRAS, NRAS and KRAS—are collectively mutated in one-third of
human cancers, where they act as prototypic oncogenes. Interestingly, there are rather …
human cancers, where they act as prototypic oncogenes. Interestingly, there are rather …
Discovering Anti-Cancer Drugs via Computational Methods
New drug discovery has been acknowledged as a complicated, expensive, time-consuming,
and challenging project. It has been estimated that around 12 years and 2.7 billion USD, on …
and challenging project. It has been estimated that around 12 years and 2.7 billion USD, on …
Ras conformational ensembles, allostery, and signaling
Ras proteins are classical members of small GTPases that function as molecular switches by
alternating between inactive GDP-bound and active GTP-bound states. Ras activation is …
alternating between inactive GDP-bound and active GTP-bound states. Ras activation is …
Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment
Commitment of stem cells to different lineages is regulated by many cues in the local tissue
microenvironment. Here we demonstrate that cell shape regulates commitment of human …
microenvironment. Here we demonstrate that cell shape regulates commitment of human …
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
C Therkildsen, TK Bergmann… - Acta …, 2014 - Taylor & Francis
Background. In metastatic colorectal cancer, mutation testing for KRAS exon 2 is widely
implemented to select patients with wild-type tumors for treatment with the monocloncal anti …
implemented to select patients with wild-type tumors for treatment with the monocloncal anti …